相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PTP1B Is an Intracellular Checkpoint that Limits T- cell and CAR T- cell Antitumor Immunity
Florian Wiede et al.
CANCER DISCOVERY (2022)
PTPN2 elicits cell autonomous and non-cell autonomous effects on antitumor immunity in triple-negative breast cancer
Pei Kee Goh et al.
SCIENCE ADVANCES (2022)
CAR T cell killing requires the IFN gamma R pathway in solid but not liquid tumours
Rebecca C. Larson et al.
NATURE (2022)
Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I+ tumors
Natalie K. Wolf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Conserved conformational dynamics determine enzyme activity
Kristiane R. Torgeson et al.
SCIENCE ADVANCES (2022)
Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase Inhibitors
Rongjun He et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Protein tyrosine phosphatase nonreceptortype 2 controls colorectal cancer development
Egle Katkeviciute et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
PTPN2 phosphatase deletion in T cells promotes anti-tumour immunity and CAR T-cell efficacy in solid tumours
Florian Wiede et al.
EMBO JOURNAL (2020)
c-di-AMP hydrolysis by the phosphodiesterase AtaC promotes differentiation of multicellular bacteria
Andreas Latoscha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Protein Tyrosine Phosphatase Non-Receptor Type 2 Function in Dendritic Cells Is Crucial to Maintain Tissue Tolerance
Larissa Hering et al.
FRONTIERS IN IMMUNOLOGY (2020)
Revisiting the PD-1 pathway
Nikolaos Patsoukis et al.
SCIENCE ADVANCES (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
T-Cell-Specific PTPN2 Deficiency in NOD Mice Accelerates the Development of Type 1 Diabetes and Autoimmune Comorbidities
Florian Wiede et al.
DIABETES (2019)
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Filipe Martins et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy
Javier Celis-Gutierrez et al.
CELL REPORTS (2019)
PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity
Martin W. LaFleur et al.
NATURE IMMUNOLOGY (2019)
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
Fernando Souza-Fonseca-Guimaraes et al.
TRENDS IN IMMUNOLOGY (2019)
Cold Tumors: A Therapeutic Challenge for Immunotherapy
Paola Bonaventura et al.
FRONTIERS IN IMMUNOLOGY (2019)
A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models
Navasona Krishnan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
Roberta Zappasodi et al.
CANCER CELL (2018)
Protein-altering variants of PTPN2 in childhood-onset Type 1A diabetes
M. Okuno et al.
DIABETIC MEDICINE (2018)
DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease
Navasona Krishnan et al.
GENES & DEVELOPMENT (2018)
MX2: a high-flux undulator microfocus beamline serving both the chemical and macromolecular crystallography communities at the Australian Synchrotron
David Aragao et al.
JOURNAL OF SYNCHROTRON RADIATION (2018)
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
Marcus Grohmann et al.
CELL (2018)
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman et al.
CELL (2018)
Deficiency in Protein Tyrosine Phosphatase PTP1B Shortens Lifespan and Leads to Development of Acute Leukemia
Samantha Le Sommer et al.
CANCER RESEARCH (2018)
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
Suzanne I. S. Mosely et al.
CANCER IMMUNOLOGY RESEARCH (2017)
PTPN2-deficiency exacerbates T follicular helper cell and B cell responses and promotes the development of autoimmunity
Florian Wiede et al.
JOURNAL OF AUTOIMMUNITY (2017)
PTPN2 regulates T cell lineage commitment and αβ versus γδ specification
Florian Wiede et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
Targeting Tyrosine Phosphatases: Time to End the Stigma
Stephanie M. Stanford et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Targeted disruption of TC-PTP in the proliferative compartment augments STAT3 and AKT signaling and skin tumor development
Hyunseung Lee et al.
SCIENTIFIC REPORTS (2017)
Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFN signaling
Claudia Penafuerte et al.
ONCOIMMUNOLOGY (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome
Elmer Hoekstra et al.
ONCOTARGET (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Leptin and Insulin Act on POMC Neurons to Promote the Browning of White Fat
Garron T. Dodd et al.
CELL (2015)
A key role for PTP1B in dendritic cell maturation, migration, and T cell activation
Cristina Martin-Granados et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2015)
PTPN2 controls differentiation of CD4+ T cells and limits intestinal inflammation and intestinal dysbiosis
M. R. Spalinger et al.
MUCOSAL IMMUNOLOGY (2015)
Hepatic Oxidative Stress Promotes Insulin-STAT-5 Signaling and Obesity by Inactivating Protein Tyrosine Phosphatase N2
Esteban N. Gurzov et al.
CELL METABOLISM (2014)
PTPN2 restrains CD8+ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice
Florian Wiede et al.
JOURNAL OF AUTOIMMUNITY (2014)
Targeting the disordered C terminus of PTP1B with an allosteric inhibitor
Navasona Krishnan et al.
NATURE CHEMICAL BIOLOGY (2014)
PTPN2 attenuates T-cell lymphopenia-induced proliferation
Florian Wiede et al.
NATURE COMMUNICATIONS (2014)
PTP1B and TCPTP - nonredundant phosphatases in insulin signaling and glucose homeostasis
Tony Tiganis
FEBS JOURNAL (2013)
Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
Stephen R. Mattarollo et al.
CANCER RESEARCH (2011)
Elevated Hypothalamic TCPTP in Obesity Contributes to Cellular Leptin Resistance
Kim Loh et al.
CELL METABOLISM (2011)
An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4+ T cells
S. A. Long et al.
GENES AND IMMUNITY (2011)
T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice
Florian Wiede et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor
Emilie Narni-Mancinelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Integration, scaling, space-group assignment and post-refinement
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Insights into the Reaction of Protein-tyrosine Phosphatase 1B CRYSTAL STRUCTURES FOR TRANSITION STATE ANALOGS OF BOTH CATALYTIC STEPS
Tiago A. S. Brandao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
PTP1B regulates Eph receptor function and trafficking
Eva Nievergall et al.
JOURNAL OF CELL BIOLOGY (2010)
Recent Advances in the Discovery of Competitive Protein Tyrosine Phosphatase 1B Inhibitors for the Treatment of Diabetes, Obesity, and Cancer
Andrew P. Combs
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia
Maria Kleppe et al.
NATURE GENETICS (2010)
Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines
Brent Douty et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression
Ben J. Shields et al.
CANCER CELL (2008)
Shared and Distinct Genetic Variants in Type 1 Diabetes and Celiac Disease
Deborah J. Smyth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
John A. Todd et al.
NATURE GENETICS (2007)
Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer
Mohamed Bentires-Alj et al.
CANCER RESEARCH (2007)
Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis
Sofi G. Julien et al.
NATURE GENETICS (2007)
Protein tyrosine phosphatase function: the substrate perspective
Tony Tiganis et al.
BIOCHEMICAL JOURNAL (2007)
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes
J Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
6,8-Difluoro-4-methylumbiliferyl phosphate:: a fluorogenic substrate for protein tyrosine phosphatases
S Welte et al.
ANALYTICAL BIOCHEMISTRY (2005)
T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease
KM Heinonen et al.
BLOOD (2004)
Allosteric inhibition of protein tyrosine phosphatase 1B
C Wiesmann et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of plague
FB Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification of a nuclear Stat1 protein tyrosine phosphatase
J ten Hoeve et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
PTP1B regulates leptin signal transduction in vivo
JM Zabolotny et al.
DEVELOPMENTAL CELL (2002)
The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3
PD Simoncic et al.
CURRENT BIOLOGY (2002)
Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum
FG Haj et al.
SCIENCE (2002)
TYK2 and JAR2 are substrates of protein-tyrosine phosphatase 1B.
MP Myers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Structural and evolutionary relationships among protein tyrosine phosphatase domains
JN Andersen et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
H Nishimura et al.
SCIENCE (2001)
Structure-based discovery of small molecule inhibitors targeted to protein tyrosine phosphatase 1B
M Sarmiento et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
